Trial intelligence / Profile preview

Comparison of ear injury with gentamicin versus amikacin in neonates

IRCT2017071920258N54Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jan 2016
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of gentamicin and amikacin in bacterial disease (2 arms), sponsored by Arak University of Medical Sciences. Started Jan 2016; status: completed.

02

Drugs

gentamicinamikacin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on IRCT2017071920258N54.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017071920258N54.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call